Reviva Pharmaceuticals Holdings, Inc. SEC filings RVPH
Reviva Pharmaceuticals Holdings, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Oct 29, 2026 | Dec 18, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 25-NSE | Delisting notice | Jul 10, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
May 13, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 15, 2026 | Apr 15, 2026 |
| S-8 | Employee stock plan registration | Mar 30, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 19, 2026 | Mar 18, 2026 |
| 424B5 | Prospectus supplement | Mar 19, 2026 | — |
| 424B5 | Prospectus supplement | Mar 18, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 5, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Jan 23, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
Dec 23, 2025 | Dec 18, 2025 |
| 25-NSE | Delisting notice | Dec 12, 2025 | — |
| DEFA14A | Additional proxy material | Dec 5, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Nov 4, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Nov 4, 2025 | — |
| DEF 14A | Proxy statement | Nov 4, 2025 | Dec 18, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 24, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 17, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 19, 2025 | Sep 18, 2025 |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B5 | Prospectus supplement | Sep 18, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 26, 2025 | Jun 26, 2025 |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| 424B5 | Prospectus supplement | Jun 25, 2025 | — |
| 8-K |
Current report
Auditor change
|
Jun 6, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 424B5 | Prospectus supplement | May 30, 2025 | — |
| 8-K |
Current report
Material agreement
|
May 30, 2025 | May 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| S-8 | Employee stock plan registration | Apr 3, 2025 | — |
| 10-K | Annual report | Apr 3, 2025 | Dec 31, 2024 |
| NT 10-K | Form nt 10-k | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2025 | Feb 13, 2025 |
| 424B5 | Prospectus supplement | Dec 18, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 18, 2024 | Dec 16, 2024 |
| 424B5 | Prospectus supplement | Dec 16, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Dec 12, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| ARS | Annual report to shareholders | Oct 28, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Oct 28, 2024 | Dec 10, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 17, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2024 | Sep 15, 2024 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Aug 22, 2024 | Aug 20, 2024 |
| UPLOAD | Letter from the SEC | Aug 22, 2024 | — |
| 424B5 | Prospectus supplement | Aug 22, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 21, 2024 | Aug 20, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| CORRESP | Letter to the SEC | Aug 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Material agreement
|
May 29, 2024 | May 28, 2024 |
| 424B5 | Prospectus supplement | May 29, 2024 | — |
| S-8 | Employee stock plan registration | May 17, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 15, 2024 | Apr 15, 2024 |
| 10-K | Annual report | Apr 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Results of operations, Restatement
|
Apr 15, 2024 | Apr 12, 2024 |
| NT 10-K | Form nt 10-k | Apr 2, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Feb 13, 2024 | — |
| 424B4 | Prospectus | Feb 13, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| S-3 | Shelf registration | Feb 2, 2024 | — |
| 8-K |
Current report
Material agreement
|
Nov 17, 2023 | Nov 15, 2023 |
| 424B5 | Prospectus supplement | Nov 17, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 14, 2023 | Nov 13, 2023 |
| 8-K/A |
Amended current report
Auditor change
|
Nov 14, 2023 | Oct 4, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| ARS | Annual report to shareholders | Oct 4, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Oct 4, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 17, 2023 | Aug 17, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Auditor change
|
Jul 24, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2023 | Jun 22, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2023 | Apr 25, 2023 |
| 424B3 | Prospectus | Apr 5, 2023 | — |
| EFFECT | Filing | Apr 4, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| POS AM | Form pos am | Mar 30, 2023 | — |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2023 | Jan 4, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Nov 14, 2022 | Nov 10, 2022 |
| 424B4 | Prospectus | Oct 18, 2022 | — |
| EFFECT | Filing | Oct 17, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2022 | — |
| DEF 14A | Proxy statement | Oct 11, 2022 | Nov 10, 2022 |
| S-1 | Registration statement | Oct 6, 2022 | — |
| D | Filing | Sep 19, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 7, 2022 | Sep 6, 2022 |
| 424B5 | Prospectus supplement | Sep 7, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Agreement ended
|
Jul 28, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 27, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2022 | Jun 23, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 424B3 | Prospectus | Mar 23, 2022 | — |
| 424B3 | Prospectus | Mar 23, 2022 | — |
| EFFECT | Filing | Mar 22, 2022 | — |
| EFFECT | Filing | Mar 22, 2022 | — |
| POS AM | Filing | Mar 18, 2022 | — |
| POS AM | Filing | Mar 18, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 15, 2022 | Mar 15, 2022 |
| 10-K | Annual report | Mar 15, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Feb 2, 2022 | — |
| 424B3 | Prospectus | Feb 2, 2022 | — |
| 424B3 | Prospectus | Feb 2, 2022 | — |
| 8-K |
Current report
Other events
|
Feb 1, 2022 | Feb 1, 2022 |
| CORRESP | Letter to the SEC | Jan 31, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2022 | — |
| 8-K |
Current report
Material agreement
|
Jan 26, 2022 | Jan 26, 2022 |
| S-3 | Shelf registration | Jan 26, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2021 | Dec 8, 2021 |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 15, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| DEF 14A | Proxy statement | Oct 26, 2021 | Dec 8, 2021 |
| 424B3 | Prospectus | Sep 21, 2021 | — |
| 424B3 | Prospectus | Sep 21, 2021 | — |
| 8-K | Current report | Sep 20, 2021 | Sep 17, 2021 |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 16, 2021 | Aug 16, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2021 | Jun 15, 2021 |
| POS EX | Form pos ex | May 28, 2021 | — |
| 424B4 | Prospectus | May 28, 2021 | — |
| EFFECT | Filing | May 26, 2021 | — |
| S-1MEF | Form s-1mef | May 26, 2021 | — |
| CORRESP | Letter to the SEC | May 25, 2021 | — |
| CORRESP | Letter to the SEC | May 25, 2021 | — |
| S-1/A | Amended registration statement | May 25, 2021 | — |
| S-1/A | Amended registration statement | May 19, 2021 | — |
| 424B3 | Prospectus | May 17, 2021 | — |
| 424B4 | Prospectus | May 17, 2021 | — |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| EFFECT | Filing | May 14, 2021 | — |
| POS AM | Form pos am | May 12, 2021 | — |
| S-1/A | Amended registration statement | May 10, 2021 | — |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 10-K/A | Amended annual report | May 7, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Restatement
|
May 7, 2021 | May 7, 2021 |
| UPLOAD | Letter from the SEC | Apr 21, 2021 | — |
| S-1 | Registration statement | Apr 19, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2021 | Apr 14, 2021 |
| 424B4 | Prospectus | Mar 29, 2021 | — |
| EFFECT | Filing | Mar 26, 2021 | — |
| POS AM | Form pos am | Mar 25, 2021 | — |
| 10-K/A | Amended annual report | Mar 24, 2021 | Dec 31, 2020 |
| S-8 | Employee stock plan registration | Mar 22, 2021 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 22, 2021 | Mar 22, 2021 |
| 10-K | Annual report | Mar 22, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Mar 4, 2021 | Mar 4, 2021 |
| 8-K/A |
Amended current report
Auditor change, Bylaw or fiscal year change
|
Jan 20, 2021 | Dec 14, 2020 |
| 424B3 | Prospectus | Jan 14, 2021 | — |
| 10-Q | Quarterly report | Jan 14, 2021 | Nov 30, 2020 |
| 424B4 | Prospectus | Jan 12, 2021 | — |
| EFFECT | Filing | Jan 11, 2021 | — |
| CORRESP | Letter to the SEC | Jan 7, 2021 | — |
| S-1/A | Amended registration statement | Jan 7, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2021 | — |
| S-1 | Registration statement | Dec 29, 2020 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Bylaw or fiscal year change
|
Dec 18, 2020 | Dec 14, 2020 |
| 25-NSE | Delisting notice | Dec 14, 2020 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Dec 14, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Dec 9, 2020 | Dec 8, 2020 |
| 8-K |
Current report
Other events
|
Nov 19, 2020 | Nov 18, 2020 |
| 425 | Form 8-k | Nov 19, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RVPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cupertino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1742927
- Former names
- Tenzing Acquisition Corp. (until Dec 14, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.